.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Musculoskeletal ultrasound in PsA has revolutionized the way clinicians manage psoriatic disease. Because psoriatic arthritis often presents with diverse clinical signs, early diagnosis remains a significant challenge for many physicians. There are no definitive serological biomarkers available for this condition. Therefore, imaging plays a critical role in identifying early structural and inflammatory changes. Specifically, ultrasound allows doctors to see subclinical synovitis and enthesitis before physical symptoms appear. This early detection is vital for disease interception and prevention.
Notably, ultrasound detects various musculoskeletal involvements across the psoriatic spectrum. It identifies peritendonitis, tenosynovitis, and bursitis with high sensitivity. Moreover, it helps in the differential diagnosis between inflammatory and non-inflammatory joint pain. For instance, clinicians can distinguish between degenerative changes and active psoriatic inflammation. Furthermore, new scoring systems like the DUET score have improved the accuracy of enthesitis assessment. Consequently, these tools support a more precise and timely diagnosis.
Beyond diagnosis, ultrasound serves as a powerful prognostic tool. It predicts future structural damage by identifying active subclinical inflammation. Consequently, this information helps rheumatologists tailor treatment plans to individual patient needs. Additionally, ultrasound is highly effective for monitoring therapeutic response. By observing changes in power Doppler signals, physicians can objectively measure the success of biological therapies. This approach ensures that patients reach their treatment targets faster. Therefore, integrating ultrasound into routine practice promotes a precision medicine approach.
Subclinical psoriatic arthritis describes a phase where psoriasis patients show ultrasound evidence of inflammation, such as enthesitis, without having visible clinical symptoms. Early identification during this stage may prevent progression to established arthritis.
Ultrasound allows clinicians to visualize inflammatory activity that clinical exams might miss. By monitoring power Doppler signals, doctors can determine if a specific drug effectively reduces inflammation or if they need to switch therapies.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult a qualified medical practitioner for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
D'Ignazio E et al. The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring. Curr Rheumatol Rep. 2026 Jun 12. doi: undefined. PMID: 42277548.
Russu E, et al. The role of musculoskeletal ultrasonography in the early diagnosis and differentiation of rheumatoid arthritis, psoriatic arthritis and cutaneous psoriasis. Medical Research Archives. 2025;13(4). doi: 10.18103/mra.v13i4.6488.
RheumNow. New Advances in Ultrasound Diagnostics for Psoriatic Arthritis - ACR Convergence 2025. Published October 25, 2025.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Musculoskeletal ultrasound is essential for managing Psoriatic Arthritis (PsA). It helps doctors detect early subclinical changes, monitor treatment response, and provide personalized care. This review highlights how imaging improves diagnostic accuracy and long-term outcomes in psoriatic disease.
last month
The Food Safety and Standards Authority of India (FSSAI) has rejected industry appeals and directed beverage manufacturers to remove the term 'energy drink' and unapproved therapeutic claims within 90 days. This regulation aims to curb misbranding and ensure clear labeling across commercial food products.
Today
Johnson & Johnson announced a $5.5 billion settlement to resolve nearly 69,000 lawsuits alleging its talc-based baby powder caused ovarian cancer. This comprehensive deal covers 99.75% of active claims. Read about the legal strategy, scientific evidence on talc exposure, and clinical counseling for patients.
Today
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
4 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
A UK Biobank study of 471,540 participants reveals that metabolic syndrome increases incident gastric cancer risk by 36% (HR=1.36). A positive trend was observed with accumulating metabolic components, with waist circumference showing the strongest association, highlighting modifiable risk targets.
4 days back
